These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 33751978)
1. Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: Design, synthesis, antiproliferative activity and DNA/RNA binding study. Lončar B; Perin N; Mioč M; Boček I; Grgić L; Kralj M; Tomić S; Stojković MR; Hranjec M Eur J Med Chem; 2021 May; 217():113342. PubMed ID: 33751978 [TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, Antitumor Activity and NMR-Based Metabolomics of Novel Amino Substituted Tetracyclic Imidazo[4,5-b]Pyridine Derivatives. Perin N; Lončar B; Kadić M; Kralj M; Starčević K; Carvalho RA; Jarak I; Hranjec M ChemMedChem; 2024 Sep; 19(17):e202300633. PubMed ID: 38757872 [TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells. Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and structure--activity relationship (SAR) studies of imidazo[4,5-b]pyridine derived purine isosteres and their potential as cytotoxic agents. Sajith AM; Abdul Khader KK; Joshi N; Reddy MN; Syed Ali Padusha M; Nagaswarupa HP; Nibin Joy M; Bodke YD; Karuvalam RP; Banerjee R; Muralidharan A; Rajendra P Eur J Med Chem; 2015 Jan; 89():21-31. PubMed ID: 25462222 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel imidazo[4,5-b]pyridine based compounds as potent anticancer agents with CDK9 inhibitory activity. Ghanem NM; Farouk F; George RF; Abbas SES; El-Badry OM Bioorg Chem; 2018 Oct; 80():565-576. PubMed ID: 30025343 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents. Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and molecular docking study of 3H-imidazole[4,5-c]pyridine derivatives as CDK2 inhibitors. Wu YZ; Ying HZ; Xu L; Cheng G; Chen J; Hu YZ; Liu T; Dong XW Arch Pharm (Weinheim); 2018 Jun; 351(6):e1700381. PubMed ID: 29708285 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel 3H-imidazole [4,5-b] pyridine derivatives as selective mTOR inhibitors. Zhang L; Bu T; Bao X; Liang T; Ge Y; Xu Y; Zhu Q Bioorg Med Chem Lett; 2017 Aug; 27(15):3395-3398. PubMed ID: 28633896 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiproliferative activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives. Kumar S; Gopalakrishnan V; Hegde M; Rana V; Dhepe SS; Ramareddy SA; Leoni A; Locatelli A; Morigi R; Rambaldi M; Srivastava M; Raghavan SC; Karki SS Bioorg Med Chem Lett; 2014 Oct; 24(19):4682-4688. PubMed ID: 25205189 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b][1,3]thiazole scaffolds. Romagnoli R; Baraldi PG; Prencipe F; Balzarini J; Liekens S; Estévez F Eur J Med Chem; 2015 Aug; 101():205-17. PubMed ID: 26141911 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents. Ullah S; El-Gamal MI; El-Gamal R; Pelletier J; Sévigny J; Shehata MK; Anbar HS; Iqbal J Eur J Med Chem; 2021 May; 217():113339. PubMed ID: 33744686 [TBL] [Abstract][Full Text] [Related]
13. Discovery and SAR study of 2-(1-propylpiperidin-4-yl)-3H-imidazo[4,5-c]pyridine-7-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1) for the treatment of cancer. Zhu Q; Wang X; Hu Y; He X; Gong G; Xu Y Bioorg Med Chem; 2015 Oct; 23(20):6551-9. PubMed ID: 26422786 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2-a]pyridine and quinazolin-4(3H)-one derivatives as PI3Kα inhibitors. Fan YH; Li W; Liu DD; Bai MX; Song HR; Xu YN; Lee S; Zhou ZP; Wang J; Ding HW Eur J Med Chem; 2017 Oct; 139():95-106. PubMed ID: 28800461 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, antiproliferative activity and DNA/RNA-binding properties of mono- and bis-(1,2,3-triazolyl)-appended benzimidazo[1,2-a]quinoline derivatives. Meščić Macan A; Perin N; Jakopec S; Mioč M; Stojković MR; Kralj M; Hranjec M; Raić-Malić S Eur J Med Chem; 2020 Jan; 185():111845. PubMed ID: 31718941 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiproliferative activity of pyrrolo[2,3-b]pyridine derivatives bearing the 1,8-naphthyridin-2-one moiety. Tang Q; Duan Y; Wang L; Wang M; Ouyang Y; Wang C; Mei H; Tang S; Xiong Y; Zheng P; Gong P; Zhu W Eur J Med Chem; 2018 Jan; 143():266-275. PubMed ID: 29197731 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of dehydroepiandrosterone-fused thiazole, imidazo[2,1-b]thiazole, pyridine steroidal analogues. Zhang BL; Song LX; Li YF; Li YL; Guo YZ; Zhang E; Liu HM Steroids; 2014 Feb; 80():92-101. PubMed ID: 24355392 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of Novel Pyridine Bearing Biologically Active Imidiazolyl, Pyrazolyl, Oxa/thiadiazolyl and Urea Derivatives as Promising Anticancer Agents. Hafez HN; El-Gazzar ABA Curr Org Synth; 2020; 17(1):55-64. PubMed ID: 32103718 [TBL] [Abstract][Full Text] [Related]
19. The discovery of novel imidazo[1,2- Song Q; Zhang Q; Fan X; Kayaat F; Lv R; Li J; Wang Y Org Biomol Chem; 2024 Jul; 22(26):5374-5384. PubMed ID: 38869445 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and antimycobacterial activity of novel imidazo[1,2-a]pyridine-3-carboxamide derivatives. Lv K; Li L; Wang B; Liu M; Wang B; Shen W; Guo H; Lu Y Eur J Med Chem; 2017 Sep; 137():117-125. PubMed ID: 28577507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]